Articles tagged with Ophthalmology
This observational study reports practice patterns among US ophthalmology practices for common ocular complaints during the initial stage of the COVID-19 pandemic. The study found that ophthalmology centers responded differently to common ocular complaints, highlighting the need for standardized care protocols.
Researchers investigated SARS-CoV-2 presence on environmental surfaces in an ophthalmology examination room. The study found detectable COVID-19 viral material on various surfaces, highlighting the need for infection control measures.
A survey study analyzed the mental state and ocular surface state of ophthalmologists and ophthalmic nurses during the COVID-19 outbreak in China. The results revealed high stress levels among healthcare professionals, which negatively impacted their ocular surface health.
Researchers at the University of Montreal have developed a synthetic, biocompatible liquid hydrogel that promotes tissue regeneration and treats corneal perforations without transplantation. This innovative solution has the potential to help patients retain their vision and avoid blindness.
Researchers have identified conjunctivitis as a potential primary symptom of COVID-19, leading to changes in patient diagnosis and treatment protocols. Ophthalmologists are now taking extra precautions when treating patients with conjunctivitis and keratoconjunctivitis, including wearing personal protective equipment.
Changes in ophthalmology practices and procedures have been reported following the COVID-19 pandemic, highlighting the need for adjustments to ensure patient safety and well-being. The study examines the impact of the pandemic on eye care services and provides insights into future directions for ophthalmology.
A new study found that very low doses of Avastin are effective in preventing blindness in preterm infants. The treatment was tested on 59 preterm infants with type 1 ROP and showed success in improving vision with minimal side effects.
A recent study highlights various COVID-19 control measures being implemented at an ophthalmology center in Singapore to mitigate the pandemic's impact on patients and staff. The clinic has adopted several initiatives, including enhanced infection control protocols, telemedicine services, and patient triage procedures.
A recent study published in Ophthalmology found no virus detected in the tears of infected patients with COVID-19, suggesting a low risk of transmission through this route. The study's authors hope their findings will guide further research into preventing virus transmission through more significant routes.
A new Penn Medicine study found that missing a single ophthalmology appointment over a two-year period was associated with decreased visual acuity for patients with macular degeneration. Patients who attended more frequent visits had better visual outcomes, highlighting the importance of visit adherence for this patient population.
Dr. Jennifer J. Lentz and her team will research a treatment for vision loss in Usher using antisense oligonucleotides, targeting the human 216A mutation in the USH1C gene. The goal is to develop an effective treatment for vision loss in Usher Syndrome.
Jayne S. Weiss, MD, has been awarded the 2020 Castroviejo Award for her outstanding work on corneal dystrophies, particularly Schnyder corneal dystrophy. Her research focuses on genetic mapping and pathophysiology of corneal diseases, making significant contributions to the field.
A new study suggests combining eye drops and contact lenses can effectively slow nearsightedness in children, with benefits seen in both high and low myopia cases. The combination treatment was found to be 28-38% more effective than using either method alone.
The American Academy of Ophthalmology honored ophthalmologists who improved eye care worldwide through their scientific contributions, international work, and advocacy efforts. The honorees included Marilyn T. Miller, Graham E. Quinn, David F. Chang, Richard L. Abbott, Ralph C. Lanciano Jr., and Marcus Ang.
A new AI screening system has been shown to accurately detect diabetic retinopathy in 95.5% of cases, making real-time screening possible for primary care practices and diabetes centers. The EyeArt system can provide a reading in 60 seconds and does not require the input of an expert ophthalmologist.
A new study links common bladder medication Elmiron to a vision-threatening eye condition, finding that about one-quarter of patients with significant exposure show signs of retinal damage. The research highlights the potential for long-term use of the drug to masquerade as other known conditions.
A new study found that cataract surgery significantly improves drivers' safety on the road. After undergoing surgery, patients experienced a 48% decrease in near misses and crashes. This improvement was due to enhanced contrast sensitivity and night vision.
Researchers have made significant progress in developing gene therapy to treat wet age-related macular degeneration (AMD). Six patients have maintained vision after receiving a single intravitreal injection of gene therapy, offering hope for a potential
A study evaluated representation of female authorships in ophthalmologic journals from 2008 to 2018. The analysis found sex-disparities exist in the field of ophthalmology research.
Dr. Jerry A. Shields, MD is honored with the 2019 Lucien Howe Medal for his distinguished service to the fields of ocular oncology and ophthalmology. He has made significant contributions to life-saving treatments and cures in eye cancer.
Despite NICE guidelines stating cataract surgery is cost-effective, NHS commissioners are restricting access to the procedure. Over 2,900 prior approval requests for cataract surgery were rejected in 2022, more than double the number two years ago.
A study by Kellogg Eye Center reveals that herpes zoster ophthalmicus (HZO) cases tripled in 12 years, mostly affecting older adults. Shingles vaccination provides strong protection from HZO complications, but its use is not widespread.
Researchers at Michigan Medicine developed a smartphone-based tool that uses artificial intelligence to analyze retinal images and detect diabetic retinopathy. The device, called RetinaScope, achieved high sensitivity and specificity rates in a study, outperforming human graders in detecting the condition.
Researchers at Mass Eye and Ear have identified microglia as gatekeepers that orchestrate inflammatory responses in the retina during autoimmune uveitis. By depleting microglia, disease was completely blocked, suggesting a novel therapeutic target for this devastating eye disease.
A recent NIH study found no evidence that eating a calcium-rich diet or taking supplements increases the risk of age-related macular degeneration. The study suggests that high calcium intake may be protective, but more research is needed to confirm this finding.
A new study published in Ophthalmology shows that AI can assist physicians in accurately diagnosing diabetic retinopathy, a potentially blinding eye disease. The researchers developed two types of assistance to help physicians read the algorithm's predictions, which improved diagnostic accuracy and confidence.
Researchers have discovered that a new imaging device can detect signs of Alzheimer's disease in just seconds. The study used optical coherence tomography angiography to analyze the retinas of patients and found altered small blood vessels indicative of the disease.
Researchers at UTHealth received grants to study the role of photoreceptors in sight and day/night vision. They aim to develop new therapeutic strategies for degenerative retinal diseases.
A clinical trial found that a minimally invasive treatment for retinal detachment resulted in better visual acuity and reduced visual distortion compared to traditional surgery. The procedure, called pneumatic retinopexy (PnR), also showed significant cost benefits for healthcare systems.
Stephen Christiansen, MD, received a Senior Achievement Award for his significant contributions to ophthalmology and pediatrics. Babak Eliassi-Rad, MD, was awarded an Achievement Award for his research and clinical work on glaucoma and cataract.
A new editorial and free resource clarify corneal dystrophy diagnoses based on corrected medical literature, with the International Committee for Classification of Corneal Dystrophies providing an updated standard classification. The IC3D nomenclature has become internationally accepted.
Researchers reviewed published studies and found at least seven patients who experienced devastating harm from unapproved cell therapy. Clinics that offer such treatments often omit poor outcomes in their reports, leading to a significant under-reporting of complications.
A recent study by the American Academy of Ophthalmology found that WebMD Symptom Checker was incorrect 74 percent of the time when diagnosing eye problems. The online tool often assesses symptom severity incorrectly, leading to inappropriate recommendations such as self-care at home instead of emergency treatment.
Two studies using optical coherence tomography angiography (OCTA) reveal altered retinal blood vessels in patients with Alzheimer's disease, even before symptoms appear. Researchers hope this new method will enable early detection and treatment of the condition.
The American Academy of Ophthalmology has received a $2 million gift from the Knights Templar Eye Foundation to establish a permanent research fund focused on pediatric ophthalmology. The fund will leverage the IRIS Registry to uncover optimal approaches to prevention and treatment for common and rare eye diseases affecting children.
The American Academy of Ophthalmology has announced the construction of a public museum dedicated to vision and eye health in San Francisco. The $12 million project will feature immersive exhibits, virtual reality headsets, and interactive screens showcasing the history of ophthalmology and its latest innovations.
Researchers have developed an implantable delivery system that enables patients to go 15 months in between treatments, significantly improving the conventional regimen of nearly monthly eye injections. The study found that patients treated with the highest drug concentration were able to maintain their vision for a longer period.
A new study suggests that excessive screen time is contributing to an increase in nearsightedness among children, with symptoms including dry eye and blurred vision. Parents can take steps to mitigate this by encouraging outdoor activities, using good posture, and taking regular breaks from screens.
Researchers have made significant progress in developing eye drops to treat age-related macular degeneration (AMD), a leading cause of blindness. The eye drops use cell-penetrating peptides to deliver therapeutic drugs to the retina, offering a convenient and potentially cost-effective alternative to injections.
A Loyola Medicine study found lax, rubbery eyelids in 53% of sleep apnea patients, associated with the most severe cases. Sleep apnea affects an estimated 34% of men and 17% of women, but up to 80% remain undiagnosed.
A comprehensive analysis of research and clinical reports reveals that psychological stress contributes to vision loss and disease progression. A holistic treatment approach combining stress management, patient education, and vision recovery techniques may be effective in interrupting this cycle.
The Institute of Molecular and Clinical Ophthalmology Basel (IOB) is a pioneering organization developing new therapies for eye diseases. With a strong interdisciplinary approach, IOB combines basic and clinical science to address global challenges like macular degeneration, glaucoma, and myopia.
A study of 140,000 people identified 133 genetic variants that could help predict the risk of developing glaucoma. These genetic markers can be measured as early as birth and may allow for earlier diagnosis and treatment.
Researchers have developed a CRISPR-based treatment that can restore retinal function in mice afflicted with retinitis pigmentosa, a degenerative eye disease. The 'ablate-and-replace' strategy allows for the precise removal and replacement of the faulty gene, enabling faster and less expensive treatment options for dominant disorders.
A study finds that ophthalmology residents face substantial burnout and depression burdens, affecting patient care. Hospitals can improve support by offering wellness programs and ensuring free time for residents.
A new AI-powered algorithm has been developed to diagnose retinopathy of prematurity (ROP), a leading cause of childhood blindness, with an accuracy rate of 91% compared to 82% for human experts. The algorithm uses deep learning to analyze images of infant eyes and can help prevent blindness in more babies worldwide.
Sylentis presents preclinical and clinical results for three ophthalmological compounds targeting dry eye syndrome, macular degeneration and eye allergies. The company is a leader in RNAi technology and has developed new treatments for ophthalmological and inflammatory illnesses.
Astronaut David Wolf shares his experience of worsening eye sight after space missions, citing a possible connection between microgravity and visual impairment. Researchers are using advanced imaging techniques to find solutions for the effects of space travel on vision, critical for future long-duration missions.
A new study published in JAMA Ophthalmology suggests that telemedicine can accurately diagnose a rare cause of blindness in premature babies. The study found no significant difference between in-person and remote exams for diagnosing retinopathy of prematurity, which affects up to 16,000 US babies each year.
A study published in the British Journal of Ophthalmology reveals that around half of vision impairment in Western Europe is preventable. The UK has a relatively low prevalence of blindness, but higher rates of moderate to severe vision impairment compared to some non-EU countries.
A new study published in the American Academy of Ophthalmology journal demonstrates an AI program that detects diabetic eye disease with improved accuracy by incorporating expert feedback from retina specialists. The research provides a groundwork for developing automated systems for screening patients at risk for diabetic retinopathy.
A new IRIS Registry-powered study explores racial and gender outcomes with minimally invasive glaucoma surgery, aiming to increase quality care for diverse patient groups. The research seeks to assess the real-world demographic differences in MIGS use, safety, and effectiveness.
A groundbreaking study has identified a new periodic autoinflammatory syndrome affecting the eyes, known as keratoendotheliitis fugax hereditaria. The disease is caused by a mutation in the NLRP3 gene and affects corneal endothelium, leading to temporary ocular inflammation.
Dr. Jerry A. Shields, a pioneering ophthalmologist, received the inaugural Brady-Shields Endowed Chair in Ocular Oncology at Wills Eye Hospital. The chair honors Dr. Luther W. Brady Jr., Dr. Carol L. Shields, and their contributions to ocular oncology research.
Researchers at University of Wisconsin-Madison have developed an improved gene delivery tactic for treating glaucoma, a leading blinding disease. The new method doubles the transfer of genes entering target cells and spreads them more uniformly across the trabecular meshwork tissue.
The special section on OCT published by SPIE Journal of Biomedical Optics highlights its continued relevance in medicine and biology. New opportunities emerge in areas like gastroenterology, dermatology, and oncology.
A study published in Ophthalmology found that art training improved medical students' observation and diagnostic skills. The study involved 36 first-year medical students who received six 90-minute art observation sessions at the Philadelphia Museum of Art, resulting in significantly improved observational skills and empathy.
A study published in JAMA Ophthalmology found that ophthalmologists' perceptions of financial and clinical productivity declined as they adopted electronic health records, while overall practice costs increased. Only one-third of surveyed ophthalmologists said they would return to paper records if possible.
A survey of 348 US ophthalmologists found that EHR adoption has more than doubled since 2011 to 72 percent. Despite this growth, most ophthalmologists reported a decrease in productivity as a result of EHR use. This study emphasizes the need for improving the efficiency and usability of EHR systems to mitigate negative perceptions.
A study found that younger ophthalmologists were more likely to be associated with patient complaints compared to their older colleagues. The Vanderbilt University Medical Center's Patient Advocacy Reporting System was used to analyze patient complaints between 2002 and 2015.